Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Cancer|October 5, 2002
Interleukin-2, interferon-alpha, 5-fluorouracil, and vinblastine in the treatment of metastatic renal cell carcinoma: a prospective phase II study: the experience of Rambam and Lin Medical Centers 1996-2000Eliahu Gez, Raphael Rubinov, Diana Gaitini, et al.
Genes|April 28, 2023
Comprehensive Genetic Analysis of Druze Provides Insights into Carrier ScreeningEden Avnat, Guy Shapira, Shelly Shoval, et al.
Breast Cancer Research and Treatment|October 21, 2010
Germline mutations in BRCA1 and BRCA2 genes in ethnically diverse high risk families in IsraelYael Laitman, Roni Tsipora Borsthein, Dominique Stoppa-Lyonnet, et al.
European Journal of Human Genetics : EJHG|July 6, 2012
Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populationsYael Laitman, Bing-Jian Feng, Itay M Zamir, et al.
Gynecologic Oncology|December 22, 2007
Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN)Hadassah Goldberg, Robert C Miller, Roxolyana Abdah-Bortnyak, et al.
The Israel Medical Association Journal : IMAJ|December 26, 2021
Oncology Treatments during the COVID-19 Pandemic in Israel: the ONCOR StudyGalit Hirsh-Yechezkel, Angela Chetrit, Sivan Ben Avraham, et al.
NPJ Breast Cancer|September 14, 2017
Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registrySalomon M Stemmer, Mariana Steiner, Shulamith Rizel, et al.
Breast Cancer Research : BCR|November 13, 2016
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 womenTimothy R Rebbeck, Tara M Friebel, Nandita Mitra, et al.
Breast Cancer Research : BCR|May 1, 2015
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriersSophie Blein, Claire Bardel, Vincent Danjean, et al.
JAMA|April 8, 2015
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancerTimothy R Rebbeck, Nandita Mitra, Fei Wan, et al.
Pageof 6